The Journal of Clinical Endocrinology and Metabolism reported that FTM patients administering SubQ testosterone were found to easily reach stable and normal testosterone levels along with suitable E2 levels
Treatment discontinuation due to adverse events occurred in 4% to 8% of individuals taking orforglipron, compared to 1% in the placebo group
(3) tonicity agents, including dextrose, glycerine, hydroxpropyl betadex, mannitol, sorbitol, potassium chloride, and sodium chloride
doi: 10.3390/md18080406, 17
Top concerns with using GLP-1s for weight loss are predatory pharmaceutical marketing practices (70%), supply chain issues for diabetes patients (63%), and prescribing behavior
The STEP 1 extension trial showed participants regained about two-thirds of lost weight within a year of stopping semaglutide (Wilding et al., 2022)